|Articles|August 9, 2019
Clear Advantages for Characterizing Critical Quality Attributes (CQAs) of Biopharmaceutical Products
Author(s)Agilent
• Streamlined separations for intact proteins, peptide mapping, glycans analysis • LC/Q-TOF enhanced workflows
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5